http://rdf.ncbi.nlm.nih.gov/pubchem/reference/9315385

Outgoing Links

Predicate Object
contentType Clinical Trial, Phase II|Journal Article|Research Support, Non-U.S. Gov't
endingPage 1827
issn 0007-0920
1532-1827
issueIdentifier 12
pageRange 1822-1827
publicationName British Journal of Cancer
startingPage 1822
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_d29184df8844e34b460482b1b6dbad96
bibliographicCitation Khan OA, Blann AD, Payne MJ, Middleton MR, Protheroe AS, Talbot DC, Taylor M, Kirichek O, Han C, Patil M, Harris AL. Continuous low-dose cyclophosphamide and methotrexate combined with celecoxib for patients with advanced cancer. Br J Cancer. 2011 Jun 07;104(12):1822–7. PMID: 21587257; PMCID: PMC3111194.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6e98e4e63200cc9ad653e7cf751c008b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_86896db983ac7507e3c9e21d9e4a32b5
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_23e95e13f0451f429945aeba2943f3d7
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8d27eeb6457979321178368fd95a73e3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_de1d31f2b3fd0a277f714cab30198602
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_6c32db50e26c376e492558c1789eb3c1
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_53222cb09df9d9b61ca7d14a51025adf
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1d8dc86e39a46642902aba1615ddf9a7
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d7841b964b9676327e8157f4c261818f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_55547eaeeb755e2f88917ce94c661708
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7f6b2cf8cb3ed350701f59c38096ec29
date 2011-05-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://doi.org/10.1038/bjc.2011.154
https://pubmed.ncbi.nlm.nih.gov/21587257
https://pubmed.ncbi.nlm.nih.gov/PMC3111194
isPartOf http://rdf.ncbi.nlm.nih.gov/pubchem/journal/1765
https://portal.issn.org/resource/ISSN/0007-0920
https://portal.issn.org/resource/ISSN/1532-1827
language English
source https://pubmed.ncbi.nlm.nih.gov/
https://www.crossref.org/
https://scigraph.springernature.com/
title Continuous low-dose cyclophosphamide and methotrexate combined with celecoxib for patients with advanced cancer
discusses http://id.nlm.nih.gov/mesh/M0270236
http://id.nlm.nih.gov/mesh/M0020790
http://id.nlm.nih.gov/mesh/M0005485
http://id.nlm.nih.gov/mesh/M0018226
http://id.nlm.nih.gov/mesh/M0170326
http://id.nlm.nih.gov/mesh/M0276185
http://id.nlm.nih.gov/mesh/M0270234
http://id.nlm.nih.gov/mesh/M0013595
hasSubjectTerm http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112
http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103
http://purl.org/au-research/vocabulary/anzsrc-for/2008/11
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_3.4.24.35
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8173
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID126941
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2907
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_1779cf3aa50c413afc7e05adb7e1b0de
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2662
http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_03d083ea0824066dd5bba237ff3a47a1

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127925204
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129872283
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129356432
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127563695
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129202881
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127719861
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129203714
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID135867281

Total number of triples: 61.